Bob Kays

Bob Kays is an experienced professional with a robust background in product management and market access within the pharmaceutical industry. Currently serving as a Product Director at Genentech since April 2015, Bob leads a team focused on implementing technology and solutions for Market Access and Contracting strategies across various product portfolios, including immunology and oncology. Previously held roles include Access Partner, Director, and Senior Strategy Manager, where Bob was instrumental in developing pricing and access strategies for key products such as Actemra, Rituxan, and Vabysmo, and navigating significant market changes including biosimilar entries. Prior experience includes work at Kaiser Permanente as a Senior Consultant and at Thermo Fisher Scientific as a Global Product Manager, along with academic roles at UC Davis. Bob holds an M.B.A. in Marketing and Technology Management and a B.S. in Genetics.